Cargando…
DMSO reduces the cytotoxicity of anticancer ruthenium complex KP1019 in yeast
Low solubility in aqueous solutions is a significant limitation of the otherwise promising anticancer ruthenium complex KP1019. In laboratory studies, this challenge is often overcome by using DMSO to help drive the drug into solution. Since DMSO was previously shown to alter the bioactivity of plat...
Autores principales: | Davis, Jonathan, Cetto, Anne, Campbell, Mary, Scoggins, Seth, Stultz, Laura, Hanson, Pamela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Caltech Library
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339913/ https://www.ncbi.nlm.nih.gov/pubmed/34377963 http://dx.doi.org/10.17912/micropub.biology.000436 |
Ejemplares similares
-
Effect of DMSO on lifespan and physiology in
C. elegans
: Implications for use of DMSO as a solvent for compound delivery
por: AlOkda, Abdelrahman, et al.
Publicado: (2022) -
Inhibitory Effects of the Ruthenium Complex KP1019 in Models of Mammary Cancer Cell Migration and Invasion
por: Bergamo, A., et al.
Publicado: (2009) -
DNA Damage Response Checkpoint Activation Drives KP1019 Dependent Pre-Anaphase Cell Cycle Delay in S. cerevisiae
por: Bierle, Lindsey A., et al.
Publicado: (2015) -
ACA-28, an anticancer compound, induces Pap1 nuclear accumulation via ROS-dependent and -independent mechanisms in fission yeast
por: Takasaki, Teruaki, et al.
Publicado: (2023) -
NAMI-A and KP1019/1339, Two Iconic Ruthenium Anticancer Drug Candidates Face-to-Face: A Case Story in Medicinal Inorganic Chemistry
por: Alessio, Enzo, et al.
Publicado: (2019)